Examining the Drivers of Racial/Ethnic Disparities in Non-Adherence to Antihypertensive Medications and Mortality Due to Heart Disease and Stroke: A County-Level Analysis

Macarius M. Donneyong, Michael A. Fischer, Michael A. Langston, Joshua J. Joseph, Paul D. Juarez, Ping Zhang, David M. KlineInternational Journal of Environmental Research and Public Health 2021 · OpenReview

TL;DR

This study investigates why Black/African Americans (BAAs) are more likely to be non-adherent to blood pressure medications and subsequently experience higher rates of heart disease and stroke mortality compared to non-Hispanic Whites (nHWs). The research highlights that county-level social and economic factors, along with clinical care access, play a significant role in explaining these disparities, and can even moderate the impact of non-adherence on mortality.

What Problem Does This Paper Address?

Hypertension is a major risk factor for heart disease and stroke, and effective management relies heavily on consistent adherence to antihypertensive medications (AHMs). However, significant racial and ethnic disparities exist in hypertension control and related mortality in the US, with Black/African Americans (BAAs) disproportionately affected. While non-adherence to AHMs is a known driver of poor outcomes, the specific factors contributing to the racial/ethnic disparities in non-adherence and how these disparities translate into differential mortality rates remain unclear. This paper aims to dissect these complex relationships by examining the role of various "determinants of health" at the county level.

Methods

The study employed a multi-faceted analytical approach:

  • Hierarchical Linear Mixed Regression (HLM): Used to assess the association between county-level determinants of health and the disparity in AHM non-adherence between BAAs and nHWs. This method accounts for the hierarchical structure of the data (counties nested within states).
  • Bayesian Paradigm Framework: Utilized to quantify the associations between AHM non-adherence and mortality (heart disease and stroke) and to investigate whether determinants of health moderate these associations. This approach allows for the modeling of complex relationships and the incorporation of uncertainty.
  • Prevalence Rate Ratio (PRR): Calculated as an index to measure the disparity in AHM non-adherence between BAAs and nHWs.
  • Shared Component/Factor Model: Applied to jointly model the log rates of heart disease and stroke mortality for both BAAs and nHWs, allowing for the estimation of unmeasured factors influencing mortality.

Datasets

The study linked two primary datasets:

  • Centers for Disease Control and Prevention (CDC) Atlas of Heart Disease and Stroke (2014–2016): Provided county-level estimates of heart disease and stroke mortality, as well as data on risk factors, social and economic factors, healthcare delivery, and costs.
  • 2016 County Health Rankings (CHR) dataset: Offered comprehensive county-level measures across four domains of determinants of health: health behaviors, clinical care, social and economic factors, and physical environment.

The analysis was conducted on 875 counties across 38 states that had sufficient populations of BAAs to enable reliable measurement of heart disease and stroke mortality rates.

Key Insights and Ideas

  • Determinants of Health Matter: The study strongly suggests that where people live—specifically the social, economic, and clinical care environments—significantly influences adherence to blood pressure medications and subsequent health outcomes.
  • Clinical Care and Socioeconomic Factors are Key Drivers: Improvements in access to affordable, quality, and timely clinical care, as well as better social and economic conditions, are associated with reduced racial disparities in AHM non-adherence.
  • Differential Moderation: The impact of AHM non-adherence on heart disease mortality is moderated by clinical care and the physical environment for BAAs, but not for nHWs. This implies that improving these factors could disproportionately benefit BAAs in mitigating the mortality risks associated with non-adherence.
  • Stroke Mortality is Complex: For stroke mortality, the moderating effects of determinants of health were less pronounced, with only social and economic factors showing a moderating effect for nHWs, but not for BAAs. This suggests that the pathways to stroke mortality may differ by race/ethnicity and the influence of these determinants.
  • Health Behaviors' Limited Role: Surprisingly, the health behavior construct was not found to be a significant predictor or moderator in the fully adjusted models, potentially due to over-adjustment or ecological fallacy.

Key Results

  • Higher Non-Adherence in BAAs: BAAs were significantly more likely to be non-adherent to AHMs, with a prevalence rate ratio (PRR) of 1.37.
  • Determinants Explain Disparities: The four county-level determinants of health constructs collectively accounted for 24% of the BAA-nHW variation in AHM non-adherence.
  • Clinical Care and Social/Economic Factors: Specifically, clinical care (β = -0.21, p < 0.001) and social and economic factors (β = -0.11, p < 0.01) were inversely associated with BAA-nHW disparities in AHM non-adherence, meaning better conditions in these areas reduced the disparity.
  • AHM Non-Adherence and Mortality: AHM non-adherence was associated with increased heart disease and stroke mortality for both BAAs and nHWs. For every standard deviation increase in AHM non-adherence, heart disease and stroke mortality increased by approximately 4.3% for BAAs and 6.5% and 3.2% respectively for nHWs.
  • Moderating Effects on Heart Disease Mortality (BAAs): Improved clinical care access (β = -0.020) and better physical environments (β = -0.018) were associated with a decrease in the impact of AHM non-adherence on heart disease mortality among BAAs.

Limitations and Future Work

  • Ecological Fallacy: The study's reliance on county-level data means findings cannot be directly inferred to individuals. Future research should incorporate individual-level data, including patient-provider relationships and trust, to confirm these associations.
  • Data Limitations: The Proportion of Days Covered (PDC) measure for adherence has limitations, not capturing all reasons for non-adherence or refill gaps. Additionally, the study was limited to older adults with Medicare Part D coverage, potentially limiting generalizability. The CHR dataset also had limited policy-related factors.
  • Future Directions: The authors suggest that interventions targeting clinical care and socioeconomic conditions in counties where BAAs reside could reduce disparities in AHM non-adherence. Improving physical environment features may also help mitigate heart disease mortality risks for BAAs. Further research is needed to understand the complex pathways for stroke mortality and the role of health behaviors at the individual level.

Summary updated

BibTeX
@article{donneyong2021examining,
  author = {Macarius M. Donneyong and Michael A. Fischer and Michael A. Langston and Joshua J. Joseph and Paul D. Juarez and Ping Zhang and David M. Kline},
  title = {{Examining the Drivers of Racial/Ethnic Disparities in Non-Adherence to Antihypertensive Medications and Mortality Due to Heart Disease and Stroke: A County-Level Analysis}},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2021},
  url = {https://openreview.net/forum?id=9QbreOATLk},
}
Figure